Nektar chief says they've solved the mystery behind the disastrous 'softening' in patient responses to '214 — spurring a rout among investors - Endpoints News

in #business5 years ago

Nektar chief says they've solved the mystery behind the disastrous 'softening' in patient responses to '214 — spurring a rout among investors - Endpoints News

Click here to read source article from Endpts.com

Summary

Nektar CEO Howard Robin says his top team has been puzzling out the reason why the response rates for their closely-watched drug NKTR-214 (bempegaldesleukin) “softened up” over time — with disastrous consequences. But the explanation didn’t satisfy anyone. In…

My Thoughts

You can't stop the future. You can't rewind the past. The only way to learn the secret...is to press play. This was a great read from Endpts and it really opened my eyes to the possibilities of the future.

Thank you for Reading!

This has been your business news update. Thank you so much for reading. I do my best to bring Steem the most up to date news. Please don't forget to leave your thoughts and comments below.


Sort:  

Warning! This user is on our black list, likely as a known plagiarist, spammer or ID thief. Please be cautious with this post!
If you believe this is an error, please chat with us in the #appeals channel in our discord.

Coin Marketplace

STEEM 0.35
TRX 0.12
JST 0.040
BTC 70638.80
ETH 3565.34
USDT 1.00
SBD 4.73